Beta-blockade reverses regional dysfunction in ischemic myocardium

Area of Science:

• Cardiology
• Pharmacology

Background:

• Myocardial compromise due to critical coronary artery constriction poses risks during anesthesia.
• Halothane, a common anesthetic, can adversely affect cardiac function, especially in compromised hearts.

Purpose of the Study:

• To investigate the protective effects of oxprenolol-induced beta-blockade.
• To assess protection against high halothane concentrations in a canine model of critical left anterior descending coronary artery constriction.

Main Methods:

• Obtained halothane dose-response curves in six dogs across three phases: control, critical constriction, and critical constriction with oxprenolol.
• Administered 0.3 mg/kg intravenous oxprenolol during the third phase.

Main Results:

• Ventricular function depression was similar across phases.
• At 2.0% inspired halothane, oxprenolol significantly minimized systolic shortening depression in the compromised segment (10.2% +/- 1.8 vs. 6.5% +/- 1.4, P < 0.05).
• Oxprenolol abolished the increase in postsystolic shortening observed during critical constriction.

Conclusions:

• Oxprenolol demonstrates a protective effect on regional myocardial function during critical coronary constriction.
• Potential mechanisms include effects on myocardial metabolism or endocardial blood flow.